bullish
Jubilant Pharma: Good Drugs, Fully-Valued Bonds
368 Views26 Jun 2020 10:43
We initiate our coverage of Jubilant Pharma Ltd (1164252D IN) (JPL) which is ranked top 2-3 global pharmaceutical company in the...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 25-minute read)
Discussions
(Paid Plans Only)
Bondcritic
Asian Fixed Income/Frontier Market Research
- Jubilant Group: Related Party Transactions and Accounting Flags22 Dec 2020
- Jubilant Pharma: Good Drugs, Fully-Valued Bonds26 Jun 2020
- Glenmark Pharma: Approval for Covid-19 Oral Drug21 Jun 2020
- Thomson Medical Group: Medicated by Leverage22 May 2020
- Glenmark Pharmaceuticals: Attempt Out of Generic12 Oct 2018
x